STAT3 and hepatocellular carcinoma: Histone H3 lysine 4 methyltransferase SMYD3 has been shown to promote the transcriptional activation of genes involved in the development of HCC, such as C-MYC, JAK/STAT3, CDK2, and MMP2 (38–40).